Misonix Announces New HIFU Distribution Agreement... ( FARMINGDALE N.Y. Jan. 5 /- Misonix In...)

Misonix Announces New HIFU Distribution Agreement for Italy

Date:1/5/2009

FARMINGDALE, N.Y., Jan. 5 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a definitive, 3-year distribution agreement with Alliance Lithomobile, a Division of Alliance Medical S.r.L., based in Milano, Italy. This agreement supersedes the interim agreement announced on November 7, 2008. Under the terms of the agreement, Lithomobile will emphasize the Sonablate(R) 500 High Intensity Focused Ultrasound ("HIFU") System as a mobile, "fee for use" service to hospitals throughout Italy. Secondarily, Alliance Lithomobile will be responsible for capital sales of the Sonablate when appropriate. Misonix and Alliance Lithomobile will share the "fee for use" revenue for the length of the agreement plus an additional 3 years. Purchase minimums for both "fee per use" and capital sales are part of the agreement.

Alliance Lithomobile is well known in Italy as a premier distributor of mobile lithotripsy services, as well as their successful representation of capital equipment for oncology and other medical specialties.

The Sonablate is a state of the art HIFU instrument used for the trans-rectal ablation of tumors of the prostate gland. Characteristics of HIFU, when used for this purpose, are clinical outcomes similar to other treatment modalities, but with low instances of urinary incontinence and sexual impotence.

"Misonix is pleased to partner with Lithomobile to provide prostate HIFU treatment for prostate cancer to hospitals throughout Italy. Lithomobile's reputation as a high-profile distributor of advanced medical equipment in Italy is well known to us," said Michael A. McManus, Jr., President and Chief Executive Officer of M
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
4. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
5. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
6. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
7. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
8. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
9. HEI, Inc. Announces Sale of RFID Division Assets
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference

Post Your Comments:

(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on

(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th

(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w

(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the

(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus

Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2 Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2 Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2

[0] Medithrive Voted #1 Medicinal Marijuana Dispensary in Bay Area [0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana [0] Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist [0] News brief -- childhood cancer survivor study report: Late recurrence is a risk for some cancers [0] Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'

... good reason to consider taking finasteride, a wel...tate and reduces the risk of getting prostate canc...ncology Group strongly suggests that for men at ri...they are most easily treatable. , It appears that...

...Risks in 236 Countries and Territories and ...on-Specific Disease Information & Vital Profiles o...he World, BALTIMORE, Sept. 11 Combining their re...health,information website ever developed for inte...

...,Imaging Ltd. (Nasdaq: EMITF ) ("EMI") announced ...e "Offering Prospectus") in Israel for the offerin...egate principal amount of,NIS 440 million. These ...provides that the maximum interest rate of the Ser...

...he most on health care when compared to other Orga...(OECD) countries. Health care prices and higher pe... spending, according to a study by researchers at ...r health resourcesphysicians, nurses and hospital ...

...ices,International Inc. (Pink Sheets: MSITF) wishe...ts VScan HIV test kit and the VScan Hepatitis C,te...allow it to apply for,EU approval of both test kit...,when EU approval is received that it will result ...

...cancer is the,second leading cause of cancer death...mately 40,460 women in the U.S. will die from the ...sed with invasive breast cancer die,from the disea...rican,American women, has teamed up with Diahann C...

Other Medicine News:Health News:Generic prostate drug helps find high-risk cancers early 2 Health News:Generic prostate drug helps find high-risk cancers early 3 Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 2 Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 3 Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 2 Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 3 Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 4 Health News:United States continues to have highest level of health spending 2 Health News:Medical Services International Inc. Completes Testing for European Union (EU) Application 2 Health News:Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer 2

Generic prostate drug helps find high-risk cancers early MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel United States continues to have highest level of health spending Medical Services International Inc. Completes Testing for European Union (EU) Application Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer

(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed

(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab

(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,

[0] Watson Files FDA Application for Generic Rozerem(R)[0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder [0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects

...ls,Inc. (Amex: ANX ), a biopharmaceutical researc...ng proprietary product candidates for the treatmen...ay that it has completed,patient enrollment in its...orelbine emulsion), a novel, emulsion formulation ...keted under the brand name Navelbine(R),is an anti...

...new,ways of treating the number-one cause of death...Investigators from Massachusetts General Hospital,...ong the time surgeons,have to correct bleeding pro...study, the surgical researchers found that profoun... not be reversed by standard,cardiopulmonary resus...

Other Medicine Technology:ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study 2 ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study 3 ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study 4 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 2 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 3 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 4 Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients 5

ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients

Ministim® MS-1B Miniature Nerve Stimulator

...ntrol allows hands-free operation in nerve locator...SoloStim provides a wide range when distant from n...ported by Life-Techs complete selection of periphe... proven ProBloc™ single injection needles an...

...u deliver unmatched performance through patient-fo...complete anesthesia solution developed, putting pa...fingertips., ,The Aisys Carestation is built on o...sia delivery and patient monitoring technology. We...

...ght polypropylene mesh which offers an excellent b...ced considerably. Optilene Mesh LP is the alternat...ocedures. It perfectly conforms,to anatomical st...e Mesh LP adapts to the movements of the patient r...

Medicine Products:

Ministim® MS-1B Miniature Nerve Stimulator SoloStim® Foot Control Aisys® Carestation®Optilene Mesh LP - Super-light and thin-walled mesh with full transparency

Misonix Announces New HIFU Distribution Agreement...( FARMINGDALE N.Y. Jan. 5 /- Misonix In...),Health